The DNA/RNA binding proteins TAR DNA-binding protein 43 (TDP-43) and fused-in-sarcoma (FUS) are genetically linked to amyotrophic lateral sclerosis and frontotemporal lobar dementia, while the inappropriate cytoplasmic accumulations of TDP-43 and FUS are observed in a growing number of late-onset pathologies including spinocerebellar ataxia 3, Alzheimer's and Huntington's diseases (HD). To investigate if TDP-43 and FUS contribute to neurodegenerative phenotypes, we turned to a genetically accessible Caenorhabditis elegans model of polyglutamine toxicity. In C. elegans, we observe that genetic loss-of-function mutations for nematode orthologs of TDP-43 or FUS reduced behavioral defects and neurodegeneration caused by huntingtin exon-1 with expanded polyglutamines. Furthermore, using striatal cells from huntingtin knock-in mice we observed that small interfering ribonucleic acid (siRNA) against TDP-43 or FUS reduced cell death caused by mutant huntingtin. Moreover, we found that TDP-43 and the survival factor progranulin (PGRN) genetically interact to regulate polyglutamine toxicity in C. elegans and mammalian cells. Altogether our data point towards a conserved function for TDP-43 and FUS in promoting polyglutamine toxicity and that delivery of PGRN may have therapeutic benefits.
INTRODUCTION
Neurons are a cell subtype sensitive to protein homeostasis and protein misfolding can lead to proteotoxic stress and eventually cell death (1) . The phenomenon has been associated with many adult-onset neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD). Two proteins that have attracted widespread interest in the field of neurodegeneration are the DNA/RNA binding proteins TAR DNA-binding protein 43 (TDP-43) and fused-in-sarcoma (FUS). Mutations in TDP-43 and FUS account for up to 6% of familial ALS, but the mislocalization of TDP-43 and FUS is observed in a growing number of age-dependent disorders including frontotemporal lobar degeneration (FTLD), Alzheimer's disease and the polyglutamine (polyQ) diseases (2) . TDP-43 and FUS are predominantly nuclear DNA/RNA-binding proteins found in cytoplasmic inclusions in the disease state (2) . TDP-43 and FUS have numerous roles in RNA homeostasis including: transcription, splicing, miRNA processing, stress granule dynamics, nucleocytoplasmic shuttling and RNA transport with local translation (2 -10) . However, it is difficult to link the normal biological function of TDP-43 and FUS to pathogenesis, since it is still unclear whether the pathogenic mechanism follows a loss of function, a toxic gain of function or both (11, 12) .
To learn more about the potential roles of TDP-43 and FUS as modifiers of age-dependent neurodegeneration, we asked whether these proteins participated in polyQ toxicity. The polyQ disorders comprise nine different orders including several ataxias as well as HD (13) . In each case, neuronal dysfunction is caused by an expansion of a polymorphic CAG tract coding for glutamine that over a specific threshold causes disease (14) . Expanded polyQs are associated with a number of phenotypes including neuronal dysfunction, oxidative stress, intracellular protein aggregation and ultimately cell * To whom correspondence should be addressed. Tel: +1 5148908000 (#28826); Email: ja.parker@umontreal.ca # The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com death (15) . A prominent feature of HD is the aggregation of mutant huntingtin protein and the recent identification of both TDP-43 (16) and FUS (17) as components of these aggregates suggests that these proteins may contribute to pathogenesis.
Since TDP-43 and FUS are evolutionarily conserved, we studied the potential role of the Caenorhabditis elegans orthologs tdp-1/TDP-43 and fust-1/FUS in regulating polyQ toxicity in a well-defined transgenic model based on the expression of human huntingtin exon-1 like proteins in worm mechanosensory neurons (18) (19) (20) . In parallel, we examined huntingtin toxicity in mammalian cells after small interfering ribonucleic acid (siRNA) knockdown of TDP-43 or FUS. We report that a reduction of TDP-43 or FUS reduced polyQ toxicity in both worm and mammalian cell models. Furthermore, the suppression of polyQ toxicity by reduction of TDP-43 was dependent on the neurotrophic factor progranulin (PGRN) in both worms and mammalian cells. Our findings suggest that TDP-43 and FUS may actively contribute to polyQ toxicity and may be new targets for therapeutic development.
RESULTS

tdp-1 and fust-1 mutations diminish neuronal dysfunction in C. elegans
To investigate the possible interaction of tdp-1, fust-1 and polyQ proteins, we used the well-characterized deletion mutants tdp-1(ok803) (21, 22) and fust-1(tm4439) (23), both of which are predicted to be null alleles ( Fig. 1A) . We examined the contribution of tdp-1(ok803) and fust-1(tm4439) to polyQ toxicity using a transgenic worm model expressing mutant huntingtin with 128 polyQ repeats (128Q) in mechanosensory neurons (19) . Transgenic 128Q animals show progressive, age-dependent loss-of-touch sensitivity compared with the wild-type polyQ control (19Q) animals or nontransgenic wild-type N2 (Fig. 1B) . Mutated tdp-1(ok803) resulted in a significant delay of age-dependent touch insensitivity ( Fig. 1C ), a phenotype we also observed with a second deletion mutant tdp-1(ok781). Similarly, the fust-1 mutation had a small but still significant protective effect on the 128Q neuronal touch response ( Fig. 1D ). We tested whether the suppression of 128Q toxicity was due to any potential effects on lifespan by the tdp-1 and fust-1 mutations. First, we observed that the expression of polyQ transgenes had no effects on lifespan compared with non-transgenic wild-type N2 worms (Supplementary Material, Fig. S1A and Table S1 ). As reported previously, we observed that tdp-1(ok803) mutants had extended lifespan compared with wild-type N2 worms (22, 23) , while fust-1(tm4439) mutants had lifespan indistinguishable to N2 worms and the lifespan of either mutant was unchanged by the expression of 128Q transgenes (Supplementary Material, Fig. S1B and Table S1 ). These data suggest that the suppression of 128Q neuronal dysfunction is not due to non-specific lifespan effects. Additionally, we tested the effects of the tdp-1(ok803) or fust-1(tm4439) mutations on the general touch response in the absence of 128Q transgenes. Since we observe the greatest suppression of 128Q toxicity up to day 3 of adulthood in 128Q worms, we performed touch response assays on N2, tdp-1(ok803) and fust-1(tm4439) animals over this time period and observed comparable levels of touch sensitivity (Supplementary Material, Fig. S1C ). Finally, the suppression of 128Q touch insensitivity was not due to transgene effects since neither tdp-1(ok803) or fust-1(tm4439) affected 128Q protein or transgene expression levels ( Fig. 1E and F, Supplementary Material, Fig. S1D ).
tdp-1 and fust-1 mutations reduce axonal degeneration HD patients and animal models display protein aggregation and neuronal degeneration (15) . The 128Q transgenic worms show several progressive phenotypes including axonal degeneration and protein aggregation (19) . These animals express soluble yellow fluorescent proteins (YFP) in mechanosensory neurons that appear as a continuous fluorescent signal along the axonal processes in young animals ( Fig. 2A ). As the 128Q animals age, the YFP signal becomes discontinuous and punctate indicating degeneration of the axonal processes ( Fig. 2B ). Additionally, in this model mutant 128Q proteins are tagged with cyan fluorescent protein (CFP), making it possible to observe aggregation phenotypes in vivo ( Fig. 2C ). Crossing the 128Q transgene into the tdp-1(ok803) background, we observed that age-dependent axonal degeneration phenotypes were significantly delayed in tdp-1(ok803); 128Q versus 128Q animals ( Fig. 2D ). Furthermore, tdp-1(ok803);128Q animals had a lower incidence of progressive axonal aggregation compared with 128Q controls ( Fig. 2E ). To test whether the C. elegans FUS ortholog fust-1 behaved similarly to tdp-1, we constructed fust-1(tm4439);128Q strains and observed that the deletion of fust-1 reduced axonal degeneration ( Fig. 2F ) and the aggregation of 128Q fusion proteins ( Fig. 2G ). These data suggest that wild-type tdp-1 and fust-1 promote polyQ-mediated neurodegeneration and aggregation phenotypes in C. elegans neurons.
TDP-1 protection is independent of HDAC6
TDP-43 is involved in many aspects of RNA metabolism. Recent work has shown a role for TDP-43 in the regulation of histone deacetylase-6 (HDAC6) mRNA when TDP-43 levels are modified (24, 25) . As HDAC inhibitors have been proposed as a therapeutic target for HD, and that HDAC6 more specifically has been reported to play a role in autophagic clearance of misfolded huntingtin proteins (26, 27) , we wondered whether HDAC6 was involved in tdp-1-mediated protection against polyQ toxicity. To address whether the C. elegans HDAC6 ortholog hdac-6 played a role in the delay of proteotoxicity when tdp-1 was absent, we constructed a tdp-1;hdac-6;128Q strain. Interestingly, the hdac-6 mutation had no effect on the tdp-1-mediated rescue of 128Q phenotypes including touch sensitivity and axonal degeneration (Supplementary Material, Fig S2A and B) . Furthermore, hdac-6 transcription was unchanged by the deletion mutants tdp-1(ok803) and tdp-1(ok781) (Supplementary Material, Fig. S2C ) suggesting that the suppression of 128Q toxicity by tdp-1 is independent of hdac-6/HDAC6 in our model. 
Suppression of polyQ toxicity by tdp-1 is dependent on progranulin
Looking at another known TDP-43 target (28) we turned to PGRN, a well-known growth factor expressed in many tissues including the central nervous system (29) , with roles in tissue repair, inflammatory response and potentially in neuronal growth (30) . Moreover, PGRN loss of function has been identified as responsible for FTLD with ubiquitinated inclusions (FTLD-U) (31, 32) and PGRN was identified in FTLD cases with TDP-43 proteinopathy (33) . The C. elegans ortholog of PGRN is PGRN-1 (30) and to address the possible role of PGRN-1 in tdp-1-mediated protection, we used the pgrn-1(tm985) null mutant in our 128Q animals (30) . Constructing tdp-1(ok803);pgrn-1(tm985);128Q and fust-1(tm4439);pgrn-1(tm985);128Q strains we observed that mutation in pgrn-1 completely abolished tdp-1-mediated neuronal protection including improved touch sensitivity ( Fig. 3A) , but pgrn-1 had no effect on the suppression of touch insensitivity by mutation of fust-1 (Fig. 3B) . Likewise, we observed that a loss of pgrn-1 blocked the suppression of axonal degeneration by tdp-1(ok803) ( Fig. 3C ), while pgrn-1(tm985) had no effect on the suppression of axonal degeneration by fust-1(tm4439) (Fig. 3D ). Finally, we looked at aggregation and observed that a loss of pgrn-1 did not block the suppression of 128Q aggregation by tdp-1(ok803) (Fig. 3E ). We observed similar results for the fust-1(tm4439);pgrn-1(tm985); 128Q strain, where pgrn-1(tm985) partially diminished the suppression of aggregation by fust-1(tm4439) in animals at days 1 and 5 of adulthood, but fust-1(tm4439);128Q and fust-1(tm4439);pgrn-1(tm985);128Q showed a similar suppression of aggregation by day 9 of adulthood ( Fig. 3F ). These data suggest that the suppression of 128Q toxicity by tdp-1/TDP-43 is dependent on pgrn-1/PGRN, while the suppression of toxicity by fust-1/FUS does not require Figure 3 . Suppression of mutant polyQ toxicity by tdp-1, but not fust-1, is dependent on PGRN. (A) tdp-1;128Q animals have increased touch sensitivity compared with 128Q animals ( * P , 0.05), but this protection was lost by mutation of PGRN in pgrn-1;tdp-1;128Q mutants. (B) tdp-1;128Q animals have decreased axonal degeneration compared with 128Q animals ( * P , 0.001), but this protection was lost by mutation of PGRN in pgrn-1;tdp-1;128Q mutants. (C) Mutation of fust-1 continues to suppress 128Q toxicity by a deletion of pgrn-1 ( * P , 0.05). (D) Mutation of PGRN does not block the suppression of axonal degeneration caused by fust-1 in fust-1(tm4439);128Q animals ( * P , 0.0001 compared with 128Q, or pgrn-1;128Q). (E) Mutation of PGRN fails to block the suppression of aggregation caused by tdp-1 in tdp-1(ok803);128Q animals ( * P , 0.0001 compared with 128Q, or pgrn-1;128Q). (F) Mutation of PGRN does not block the suppression of aggregation caused by fust-1 in fust-1(tm4439);128Q animals ( * P , 0.05 compared with 128Q, and P , 0.0001 with pgrn-1;128Q).
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pgrn-1/PGRN, thus placing tdp-1/TDP-43 and fust-1/FUS in separate pathways. Furthermore, these data suggest that pgrn-1's role in modulating neuronal dysfunction and neurodegeneration caused by 128Q can be uncoupled from aggregation. A loss of pgrn-1 had negligible effects on aggregation in tdp-1(ok803);pgrn-1(tm985);128Q and fust-1(tm4439); pgrn-1(tm985);128Q worms, despite the fact that pgrn-1 is required for the suppression of 128Q-mediated neuronal dysfunction and degeneration by tdp-1(ok803).
Reducing TDP-43 and FUS protect against mutant huntingtin toxicity in mammalian cells
Since HD primarily affects striatal and cortical neurons, we turned to cell lines generated by the conditional immortalization of striatal precursors from embryos of the Hdh Q111 knock-in mouse. These cells are known as STHdh Q111/Q111 and express full-length huntingtin with an expanded mutant polyQ allele (111 glutamines). These cells, along with the wild-type STHdh Q7/Q7 controls containing a non-pathogenic polyQ repeat (7 glutamines), express full-length huntingtin from its normal chromosomal location at endogenous, physiological levels (34) .
To investigate whether TDP-43 or FUS promotes mutant huntingtin toxicity, we opted to reduce the expression of these genes using a siRNA approach. These STHdh cells undergo cell death when stressed (35) , providing a convenient system to investigate whether TDP-43 or FUS contributes to polyQ toxicity. We observed that two out of the three test siRNAs significantly reduced the level of TDP-43 protein compared with control siRNA, in both the STHdh Q7/Q7 and STHdh Q111/Q111 cells (Fig. 4A ). Interestingly, we observed a significant reduction in cell death for STHdh Q111/Q111 cells treated with the validated TDP-43 siRNAs, with no effect on the STHdh Q7/Q7 control cell line ( Fig. 4B ). We observed similar results for FUS, where two out of the three test siRNAs effectively reduced the level of FUS protein that likewise corresponded to decreased cell death for STHdh Q111/Q111 cells, with no effect on the STHdh Q7/Q7 controls ( Fig. 4C and D). We confirmed these findings with an alternate method to score cell death using flow cytometry, where we again observed that siRNAs against TDP-43 or FUS reduced cell death in STHdh Q111/Q111 cells with no effect on STHdh Q7/Q7 control cells ( Supplementary Material, Fig. S3 ). As in worms, these data demonstrate that wild-type TDP-43 and FUS promote mutant huntingtin toxicity suggesting that this may be a conserved pathogenic mechanism.
Progranulin protects against mutant huntingtin toxicity
Data from our C. elegans 128Q model demonstrated that pgrn-1 modulates polyQ toxicity. To test whether this was conserved in our mammalian StHdh model, we first examined the consequences of siRNA-mediated inhibition of PGRN. We observed that one of three PGRN siRNAs tested enhanced cell death in STHdh Q111/Q111 cells with no significant effect on STHdh Q7/Q7 controls ( Fig. 5A and B) . Consistently, we observed that overexpression of human PGRN suppressed cell death in STHdh Q111/Q111 cells with no significant effect on STHdh Q7/Q7 control cells ( Fig. 5C and D) . Collectively, these data suggest that PGRN is a conserved modifier of mutant huntingtin toxicity.
TDP-43, but not FUS, requires PGRN for neuroprotection against mutant huntingtin
Our genetic analysis of polyQ toxicity in worms showed that PGRN is required for neuroprotection by deletion of TDP-43, but that PGRN is dispensable for suppression of toxicity via FUS loss of function. First, we confirmed the efficacy of downregulation of protein levels by single or double siRNA treatments in STHdh Q7/Q7 and STHdh Q111/Q111 cells (Fig. 6A ). We confirmed our previous results showing that TDP-43 or FUS siRNA reduced cell death, while PGRN siRNA enhanced cell death in STHdh Q111/Q111 cells, and no significant effects were observed for any siRNA treatment in STHdh Q7/Q7 cells (Fig. 6B ). Looking at the dual siRNA experiments for the STHdh Q111/Q111 cells, we observed that PGRN siRNAs abolished the protective effects of TDP-43 siRNAs (Fig. 6B) . Meanwhile, siRNAs against PGRN failed to block the protective effects of FUS siRNAs against cell death in the STHdh Q111/Q111 cells. In sum, these data are consistent with our C. elegans data and demonstrate that TDP-43 and PGRN work in the same pathway to regulate mutant huntingtin toxicity, while FUS may operate in a separate or parallel pathway to PGRN.
DISCUSSION
Late-onset diseases are responsible for a growing number of fatal and untreatable disorders within our aging population. Thus, finding effective treatments is becoming a major societal challenge. Despite the fact that TDP-43 and FUS are becoming increasingly linked to late-onset diseases (2), very little is known about their role as modifiers of disease.
In this work, we demonstrated that tdp-1 and fust-1, the orthologs of human TDP-43 and FUS, respectively, have the capacity to reduce protein toxicity in a nematode model of polyQ toxicity by reducing age-dependent neuronal dysfunction, neurodegeneration and aggregation phenotypes. The reduction of neuronal proteotoxicity by tdp-1 is not restricted to mutant polyQ as tdp-1 mutants have been reported to suppress toxicity caused by mutant SOD1 (23) as well as TDP-43 and FUS (22) . However, fust-1 was not observed to modify SOD1 toxicity in worms (23), while we see the suppression of mutant polyQ phenotypes. Nonetheless, TDP-43 and FUS may be general modifiers of late-onset proteotoxicity.
We validated the neuroprotective effects of reducing TDP-43 or FUS against mutant polyQ toxicity in mammalian neurons, suggesting that this may be a highly conserved mechanism worth examining in mouse models or HD patients. There is great interest in determining the genetic and molecular interactions of TDP-43 and FUS in relation to their normal biological functions as well as their roles in several late-onset neurodegenerative diseases (12) . Genetically tractable model organisms including worms (22, 23) , flies (36, 37) and fish (38) have begun to explore the interactions of the wild-type and mutant forms of these proteins. In particular, studies Human Molecular Genetics, 2013, Vol. 22, No. 4 787 from flies (36) and fish (38) place FUS genetically downstream from TDP-43 in terms of their normal biological function. Our previous study examining the neurotoxic effects of mutant TDP-43 and FUS proteins on C. elegans' motor neurons places wild-type tdp-1/TDP-43 downstream from the mutant proteins (22) , suggesting that the biologically normal and pathological states may not be genetically equivalent. In this current study, we place wild-type tdp-1/TDP-43 and fust-1/FUS genetically downstream from mutant polyQ toxicity. TDP-43 (16, 39) and FUS (17) are known to colocalize to polyQ aggregates in patient tissue and cell culture models, but the molecular basis for these interactions is not fully known. However, more is known about TDP-43 where it has been shown that TDP-43 contains a glutamine/asparagine (Q/N)-rich domain in its C-terminal that is responsible for binding to polyQ aggregates (39) . It has been shown that mutant polyQ sequesters TDP-43 from the nucleus into cytoplasmic inclusions. This leads to toxicity because TDP-43 is depleted from the nucleus, and it can no longer perform its normal RNA processing functions. In this model, toxicity can be partially alleviated by increasing TDP-43 expression to offset its cytoplasmic entrapment (39) . These findings are not completely compatible with our findings, but this likely reflects the many complex cellular roles of TDP-43. For instance, many groups have shown that increased expression Human Molecular Genetics, 2013, Vol. 22, No. 4 789 of wild-type TDP-43 is cytotoxic and is sometimes as toxic as mutant TDP-43 (40 -49) . Furthermore, we have shown that a loss of tdp-1/TDP-43 function renders worms sensitive to cellular stress, perhaps by nuclear depletion, but alleviates proteotoxic stress caused by mutant TDP-43 or FUS (22) . Thus, we propose that wild-type tdp-1/TDP-43 contributes to cellular toxicity propagated by mutant proteins including polyQ, TDP-43 and FUS. In this context, we consistently observe that inhibition of tdp-1/TDP-43 suppresses proteotoxicity. TDP-43 and FUS have many thousands of targets (50) but nothing is known about which, if any, contribute to polyQ toxicity. As an initial foray into this area, we looked at two targets, HDAC6 and PGRN, in our 128Q worm model. HDAC6 is already known to modify polyQ toxicity (26, 27) and was an obvious first choice. However, hdac-6 had no effect on the tdp-1 mediated suppression of 128Q toxicity. The second gene we examined was PGRN, a known partner of TDP-43 in FTLD (33, 51) . In parallel, PGRN has also been identified as a TDP-43 mRNA target (28) , which indicated a potential interaction between the two genes. PGRN is a well-studied factor involved in many biological processes including neuroprotection (52) . Work from C. elegans and cultured cells suggests a critical role of PGRN in cell survival, as mutation of worm pgrn-1 results in increased apoptotic clearance in C. elegans (30) and increased sensitivity to oxidative stress and excitotoxicity in cell culture (53) . The genetic accessibility of our models allowed us to identify pgrn-1/ PGRN as a downstream effector of tdp-1/TDP-43 in regulating polyQ toxicity. Of interest is the observation that pgrn-1/ PGRN does not appear to play a role in the modulation of polyQ toxicity by fust-1/FUS. We validated these genetic interactions in mammalian neurons again demonstrating a link between TDP-43 and PGRN (but not FUS and PGRN) in regulating huntingtin toxicity, suggesting that this may be a highly conserved mechanism worth examining in more advanced mammalian models and HD patients. Summarizing our findings we propose two pathways regulating polyQ toxicity, where PGRN is downstream from TDP-43, while FUS operates independently of PGRN (Fig. 7) .
Recent reports from zebrafish models show that PGRN promotes motor neuron development (54) and that PGRN overexpression can rescue TDP-43-dependent neuropathy (55) . However, the molecular relationship between TDP-43 and PGRN is unclear, since it has been reported that a mutation in PGRN causes caspase mediated TDP-43 cleavage (56), but this has not been observed in all instances (57, 58) . 
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Human Molecular Genetics, 2013, Vol. 22, No. 4 Furthermore, while PGRN has the capacity to modulate toxicity of TDP-43, PGRN overexpression had no effect on SOD1, another ALS related protein, suggesting a more diverse role of TDP-43 in neurodegeneration.
We do not believe that the regulation of polyQ toxicity by pgrn-1/PGRN is linked to aggregation, as pgrn-1 had negligible effects on 128Q aggregation in worms whether neuronal dysfunction and neurodegeneration phenotypes were rescued or not. Furthermore, despite expressing full-length huntingtin, the STHdh cells do not display aggregation phenotypes (34) ; thus, the modulation of cell death by TDP-43, FUS or PGRN is likely independent of aggregation dynamics.
In summary, tdp-1/TDP-43 and fust-1/FUS are conserved modifiers of mutant polyQ toxicity. More work is required to fully understand the molecular mechanisms but targeted manipulation of TDP-43, FUS and/or their specific targets may have therapeutic relevance. Furthermore, delivery of PGRN to diseased polyQ neurons may be a promising strategy to boost neuronal survival against misfolded proteins.
MATERIALS AND METHODS
C. elegans experiments
Worm strains and maintenance Worms were cultured and handled by standard methods. All experiments were done at 208C. The mutant and transgenic strains used in the experiments were: igIs1[mec-3::htt57Q128: :CFP;mec-7::YFP;lin-15(+)], igIs245[mec-3::htt57Q19::CFP; mec-7::YFP;lin-15(+)] (characterized in (16)), tdp-1(ok803), fust-1(tm4439), hdac-6(ok3203) and pgrn-1(tm985). Mutant strains were obtained from the C. elegans Genetics Center (CGC, University of Minnesota, Minneapolis, USA) or from National Bioresource Project (Japan). The deletion mutants crossed to polyQ transgenic strains were verified by PCR and each had been outcrossed a minimum of three times prior to use. All strains were maintained at 208C on Escherichia coli OP50 bacteria.
Behavioral tests
Touch tests were conducted as described previously (59) . Sensitivity to mechanical sensations was scored at adult days (Ad) 1 to 11 by touching the nematode's tail 10 times and analyzed as the percentage of response. A minimum of 100 animals was tested per genotype. The mean and standard deviation are reported for each group of worms per age tested.
Fluorescence microscopy test
Axonal counts were scored in worms at days 1, 5 and 9 of adulthood for axonal dystrophy, axonal degeneration and axonal aggregation. Worms were immobilized in 5 mM levamisole and placed on a 2% agarose pad to carry out in vivo axonal examination. A minimum of 100 worms was scored over 4 -6 trials for each condition. Nematodes were examined on a Leica DM6000 microscope using a Leica DFC480 camera.
Lifespan assays
Worms were grown on nematode growth media (NGM) and transferred to NGM-FUDR plates. Twenty animals per plate by triplicates were tested at 208C from Ad 1 until death. Worms were declared dead if they did not respond to tactile or heat stimulus.
RNA extraction and reverse transcription-PCR
Worms were grown on standard NGM media, washed with M9 buffer and the pellet was stored at 2808C overnight. The frozen pellet was thawed on ice and 400-500 ml of Trizol (Invitrogen) reagent was added and the solution was incubated for 5 min at RT. Then, 150 ml of chloroform was added and the worm solution was incubated for 5 min at RT. After incubation, the solution was centrifuged at 12 000g for 15 min at 48C. RNA (aqueous phase) was transferred into a new tube and precipitated with 500 ml of isopropyl alcohol with incubation for 15 min at RT. RNA/alcohol solution was then centrifuged at 12 000g for 15 min at 48C. The supernatant was eliminated and the pellet washed with 500 ml of 75% ethanol, vortexed and centrifuged at 7500g for 15 min at 48C. The supernatant was eliminated and the pellet air-dried. RNA was resuspended in 50 ml of RNase free water, incubated at 558C for 10 min and stored at 2808C. For reverse transcription (RT) PCR, complementary DNA (cDNA) was obtained using a QuantiTect Reverse Transcription kit (QIAgen). To perform the RNA cleaning, 1 ml of genomic deoxyribonucleic acid wipeout, 500 ng of RNA and H 2 O for a total volume of 7 ml were incubated for 2 min at 428C. For the reverse transcription, the 7 ml of the previous mix was added to a PCR mix (0.5 ml of primers, 0.5 ml of reverse transcriptase and 2 ml of RT buffer). The mix was incubated for 15 min at 428C and 3 min at 958C.
Worm lysates
Worms were collected in M9 buffer, washed three times with M9 and the pellets were placed at 2808C overnight. The pellets were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris, pH 7.4, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate) + 0.1% protease inhibitors (10 mg/ml leupeptin, 10 mg/ml pepstatin A, 10 mg/ml chymostatin LPC;1/ 1000). The pellets were passed through a 27 1/2 G syringe 10 times, sonicated and centrifuged at 16 000g. The supernatant was collected. For 128Q transgenic protein solubility, the worms were lysed in extraction buffer (1 M Tris -HCl, pH 8, 0.5 M EDTA, 1 M NaCl, 10% NP40 + protease inhibitors (LPC;1/1000)). The pellets were passed through a 27 1/2 G syringe 10 times, sonicated and centrifuged at 100 000g for 5 min. The supernatant was stored as 'S' (soluble) fraction and the remaining pellet was resuspended in extraction buffer, sonicated and centrifuged at 100 000g for 5 min. The remaining pellet was resuspended in 100 ml of RIPA buffer, sonicated until the pellet was resuspended in solution and stored as sample 'P' (pellet). The pellets were passed through a 27 1/2 G syringe 10 times, sonicated and centrifuged at 16 000 g. The supernatant was stored as 'total protein extract' and the remaining pellet was resuspended in extraction buffer, sonicated and centrifuged at 100 000g for 5 min. The supernatant was stored as 'S' (soluble) fraction and the remaining pellet was resuspended in extraction buffer, sonicated and centrifuged at 100 000g for 5 min. The remaining pellet was resuspended in 100 ml of RIPA buffer, sonicated until the pellet was resuspended in solution and stored as sample 'P' (pellet).
Striatal cell experiments
TDP-43, FUS and PGRN experiments
Mouse striatal cells STHdh Q7/Q7 and STHdh Q111/Q111 were grown in Dulbecco's modified Eagle's medium (4.5 g/l glucose, 10% FBS, 100 U/ml penicillin/streptomycin, 2 mM glutamine) at 338C, 5% CO 2 . The cell were plated (1 × 
Cloning of human PGRN
A cDNA sequence encoding the human PGRN (NP_002078.1) with a C-terminal polyhistidine tag was amplified by PCR, cloned into a pcDNA3.1/TOPO vector (Invitrogen), and ampicillin-resistant colonies were identified, cultured, verified by restriction digest and DNA sequencing. Bacterial colonies with plasmid containing human PGRN were cultured and purified using a MiniPrep kit (Roche) and were expressed.
Cell death assay
After 72 h of siRNA treatment, the cell media were replaced by normal media with 200 mM sodium arsenite. After 6 h treatment, the media, which contains dead cells, were recuperated and the cells were harvested with 0.05% trypsin (Multicell). The cells were then centrifuged for 3 min, 5000 rpm at 48C and the pellet was resuspended in cold phosphate buffered saline. A fraction of the cell suspension was mixed with an equal volume of Trypan blue (Multicell) and placed on a hemacytometer. Cell death proportions were calculated by counting the number of dead cells, appearing blue because of the dye and the number of living cells.
Fluorescence-activated cell sorting
The fluorescence-activated cell sorting experiments were performed using the PE AnnexinV Apoptosis detection kit I (BD Bioscience) following the manufacturer's instructions. Annexin + cells are shown in Supplementary Material, Fig. S3 . Data acquisition was performed with a BD LSR II flow cytometry (BD Biosciences) and the data were analyzed with FlowJo (Treestar, Ashland, OR, USA).
Cell lysates
Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris pH 7.4, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate) + 0.1% protease inhibitors (10 mg/ml leupeptin, 10 mg/ml pepstatin A, 10 mg/ml chymostatin LPC;1/ 1000). The cells were lysed, incubated on ice for 10 min, then moved at RT for 10 min and finally centrifuged at 16 000g for 10 min. Protein quantification was performed using a BCA protein assay kit (Thermo Scientific).
Immunoblot
For cell experiment, the following antibodies were used: rabbit anti-TDP-43 (1/1000; Proteintech), rabbit anti-FUS (1/2000; ab23439 Abcam), sheep anti-PGRN (1/100; Abcam), rabbit anti-PGRN (1/300; Invitrogen) and mouse anti-actin (1/400 000; MP Biomedicals). For worms, rabbit anti-GFP (1/5000; ab6556, Abcam) and mouse anti-actin (1/2000; MP Biomedicals) were used.
Statistics
Statistical analysis of nematode touch-test data and cell death assays were performed using one-way ANOVA, with correction for multiple testing by Tukey -Kramer's multiple comparison test. For the touch-test experiments, data were expressed as mean + SD for .100 nematodes in each group. All experiments were repeated at least three times. P , 0.05 was considered significant.
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